Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL)Peter Pickkers, Derek C. Angus, Kristie Bass et al.|Intensive Care Medicine|2024Cited by 67
Prevention and treatment of coagulopathy in patients receiving massive transfusionsMarcel Levi, Hendrik W. Reesink, Michael T. Ganter et al.|Vox Sanguinis|2011Cited by 61
Changes in characteristics and outcomes of critically ill COVID-19 patients in Tyrol (Austria) over 1 yearTimo Mayerhöfer, Michael Joannidis, Sebastian Klein et al.|Wiener klinische Wochenschrift|2021Cited by 23
Incidence, risk factors and outcome of acute kidney injury in critically ill COVID-19 patients in Tyrol, Austria: a prospective multicenter registry studyTimo Mayerhöfer, Michael Joannidis, Fabian Perschinka et al.|Journal of Nephrology|2023Cited by 14
Elevated HbA1c remains a predominant finding in severe COVID-19 and may be associated with increased mortality in patients requiring mechanical ventilationSebastian Klein, Claudius Thomé, Timo Mayerhöfer et al.|Critical Care|2021Cited by 12